2022 Savings Offer for AJOVY is here. Learn more

Frequently asked questions

Efficacy results for AJOVY

With AJOVY, patients may experience significantly more migraine-free days vs placebo, and lasting protection against migraine1*

Learn more about efficacy results for AJOVY

*“Lasting protection” defined as reduction in monthly average migraine or headache days measured over a 12-week period following a monthly 225 mg SC dose or quarterly 675 (225 mg x 3) SC dose.1

SC: subcutaneous.